Biocon Limited vs Immunovant, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Biocon Limited and Immunovant, Inc. are worth about the same: $6.4 B and $6.6 B (market caps of Nov 20, 2026 for Biocon Limited and Oct 7, 2026 for Immunovant, Inc.).
- Biocon Limited made a net profit of $42 M, while Immunovant, Inc. made a net loss of $506 M.
- Biocon Limited employs more people: 12,000 against 70 at Immunovant, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Side by side
| Measure | Biocon Limited BIOCON.BO · #2,992 in the world | Immunovant, Inc. IMVT · #2,921 in the world |
|---|---|---|
| Profile | ||
| Country | 🇮🇳 India | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 1978 | 2018 |
| Size | ||
| Market cap | $6.4 B | $6.6 B |
| Revenue | $1.8 B | — |
| Net income | $42 M▲ best | $-506 M |
| Employees | 12,000 | 70 |
| Valuation | ||
| P/E ratio | 154× | — |
| Price to sales | 3.5× | — |
| Price to book | 1.6× | 7.8× |
| Free cash flow yield | — | -6.1% |
| Profitability | ||
| Return on equity | — | -64.8% |
| Altman Z-score zone | — | — |
| Data as of | Market cap Nov 2026 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Biocon Limited or Immunovant, Inc.?
Biocon Limited and Immunovant, Inc. are worth about the same: $6.4 B and $6.6 B (market caps of Nov 20, 2026 for Biocon Limited and Oct 7, 2026 for Immunovant, Inc.).
Which makes more money, Biocon Limited or Immunovant, Inc.?
Biocon Limited made a net profit of $42 M, while Immunovant, Inc. made a net loss of $506 M.
Which has more employees, Biocon Limited or Immunovant, Inc.?
Biocon Limited employs more people: 12,000 against 70 at Immunovant, Inc.